Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-surgery letrozole with or without megestrol acetate for postmenopausal ER-positive early breast cancer
ISRCTN15621797Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Jul 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 2, randomised, open-label trial of letrozole and megestrol in breast cancer (3 arms), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Change in tumor proliferation by Ki67. Started Jul 2017; status: completed.
02
Drugs
letrozolemegestrol
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN15621797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15621797.